VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Saturday, January 10, 2026

Stock Comparison

Waters Corporation vs Wolters Kluwer N.V.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Waters Corporation

WAT · New York Stock Exchange

Market cap (USD)$23.7B
Gross margin (TTM)
Operating margin (TTM)
Net margin (TTM)
SectorHealthcare
Industry
CountryUS
Data as of2026-01-09
Moat score
66/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Waters Corporation's moat claims, evidence, and risks.

View WAT analysis

Wolters Kluwer N.V.

WKL · Euronext Amsterdam

Market cap (USD)$21.4B
Gross margin (TTM)66.5%
Operating margin (TTM)24.8%
Net margin (TTM)18.3%
SectorIndustrials
IndustrySpecialty Business Services
CountryNL
Data as of2025-12-29
Moat score
73/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Wolters Kluwer N.V.'s moat claims, evidence, and risks.

View WKL analysis

Comparison highlights

  • Moat score gap: Wolters Kluwer N.V. leads (73 / 100 vs 66 / 100 for Waters Corporation).
  • Segment focus: Waters Corporation has 4 segments (34.9% in Waters instrument systems); Wolters Kluwer N.V. has 5 segments (26.8% in Health).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
  • Moat breadth: Waters Corporation has 7 moat types across 2 domains; Wolters Kluwer N.V. has 6 across 2.

Primary market context

Waters Corporation

Waters instrument systems

Market

Liquid chromatography (LC/UPLC) and mass spectrometry (MS) analytical instrument systems (including LC-MS workflows and instrument control/data system software)

Geography

Global

Customer

Pharma/biotech, industrial, academic and government laboratories

Role

OEM + software/platform provider

Revenue share

34.9%

Wolters Kluwer N.V.

Health

Market

Clinical decision support and clinical drug information solutions (point-of-care) for healthcare providers

Geography

Global

Customer

Hospitals/health systems, clinicians, payers, and academic institutions

Role

Software + expert content provider

Revenue share

26.8%

Side-by-side metrics

Waters Corporation
Wolters Kluwer N.V.
Ticker / Exchange
WAT - New York Stock Exchange
WKL - Euronext Amsterdam
Market cap (USD)
$23.7B
$21.4B
Gross margin (TTM)
n/a
66.5%
Operating margin (TTM)
n/a
24.8%
Net margin (TTM)
n/a
18.3%
Sector
Healthcare
Industrials
Industry
n/a
Specialty Business Services
HQ country
US
NL
Primary segment
Waters instrument systems
Health
Market structure
Oligopoly
Oligopoly
Market share
n/a
85%-90% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
66 / 100
73 / 100
Moat domains
Demand, Supply
Demand, Legal
Last update
2026-01-09
2025-12-29

Moat coverage

Shared moat types

Data Workflow LockinBrand TrustLong Term Contracts

Waters Corporation strengths

Design In QualificationInstalled Base ConsumablesSupply Chain ControlService Field Network

Wolters Kluwer N.V. strengths

Suite BundlingCompliance AdvantageSwitching Costs General

Segment mix

Waters Corporation segments

Full profile >

Waters instrument systems

Oligopoly

34.9%

Chemistry consumables

Competitive

19.1%

Waters service & software maintenance

Competitive

34%

TA instrument systems & service

Oligopoly

12%

Wolters Kluwer N.V. segments

Full profile >

Health

Oligopoly

26.8%

Tax & Accounting

Oligopoly

26.4%

Financial & Corporate Compliance

Oligopoly

20.8%

Legal & Regulatory

Oligopoly

16%

Corporate Performance & ESG

Competitive

10.1%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.